We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
(+14%)
Cap. Flow
+$7.27B
Cap. Flow
% of AUM
9.7%
Top 10 Holdings %
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.04B |
| 2 |
Microsoft
MSFT
|
+$830M |
| 3 |
Amazon
AMZN
|
+$550M |
| 4 |
Johnson & Johnson
JNJ
|
+$483M |
| 5 |
Apple
AAPL
|
+$470M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$474M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$435M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$428M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$371M |
| 5 |
Micron Technology
MU
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 13.75% |
| 3 | Healthcare | 12.4% |
| 4 | Financials | 7.81% |
| 5 | Industrials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Absci
ABSI
$1.17B
| $5.65M | 0.01% |
1,833,902
+347,079
| +23% | +$1.61M |
|
|
PPLI
927
People Inc
PPLI
$3.12B
| $5.64M | 0.01% |
+146,849
| New | +$6.07M |
|
928
Kratos Defense & Security Solutions
KTOS
$8.23B
| $5.64M | 0.01% |
282,053
+224,850
| +393% | +$4.39M |
|
929
Universal Technical Institute
UTI
$2.26B
| $5.64M | 0.01% |
358,345
-127,579
| -26% | -$1.91M |
|
930
Peabody Energy
BTU
$2.54B
| $5.62M | 0.01% |
253,913
+5,281
| +2% | +$122K |
|
931
Ultrapar
UGP
$6.66B
| $5.59M | 0.01% |
1,429,946
+1,099,433
| +333% | +$5.28M |
|
|
932
Vanguard S&P 500 ETF
VOO
$956B
| $5.59M | 0.01% |
11,177
-888,823
| -99% | -$428M |
|
|
DCBO
933
Docebo
DCBO
$559M
| $5.51M | 0.01% |
142,507
+94,414
| +196% | +$3.88M |
|
934
Acrivon Therapeutics
ACRV
$61.2M
| $5.5M | 0.01% |
948,866
+351,397
| +59% | +$2.83M |
|
|
VRE
935
DELISTED
Veris Residential
VRE
| $5.5M | 0.01% |
+366,809
| New | +$5.47M |
|
936
PTC Therapeutics
PTCT
$6.18B
| $5.49M | 0.01% |
179,679
+157,460
| +709% | +$5.1M |
|
|
EDR
937
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $5.49M | 0.01% |
203,233
-672,449
| -77% | -$17.9M |
|
938
AutoNation
AN
$7.7B
| $5.47M | 0.01% |
34,349
-60,240
| -64% | -$9.83M |
|
939
Encore Capital Group
ECPG
$2.01B
| $5.43M | 0.01% |
130,127
+89,596
| +221% | +$3.86M |
|
940
Santander
BSBR
$38.2B
| $5.43M | 0.01% |
1,099,003
+335,915
| +44% | +$1.8M |
|
941
Cadre Holdings
CDRE
$1.31B
| $5.43M | 0.01% |
161,771
-180,081
| -53% | -$5.93M |
|
942
Endava
DAVA
$165M
| $5.43M | 0.01% |
185,578
-445,570
| -71% | -$13.2M |
|
943
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.81B
| $5.43M | 0.01% |
183,305
+94,751
| +107% | +$2.77M |
|
944
Allegion
ALLE
$13.5B
| $5.42M | 0.01% |
+45,900
| New | +$5.66M |
|
945
Inspire Medical Systems
INSP
$1.47B
| $5.42M | 0.01% |
+40,473
| New | +$7.66M |
|
946
PACCAR
PCAR
$70.5B
| $5.4M | 0.01% |
52,424
-106,324
| -67% | -$11.7M |
|
947
CVS Health
CVS
$135B
| $5.36M | 0.01% |
90,728
-1,587,180
| -95% | -$99.3M |
|
|
AGR
948
DELISTED
Avangrid, Inc.
AGR
| $5.35M | 0.01% |
150,602
+136,573
| +974% | +$4.93M |
|
949
Leidos
LDOS
$14.4B
| $5.34M | 0.01% |
+36,590
| New | +$5.11M |
|
950
Dave Inc
DAVE
$4.82B
| $5.34M | 0.01% |
+176,160
| New | +$7.15M |
|
Similar funds
Marshall Wace's Q2 2024 Portfolio in Review
As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.
- Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
- Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
- Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
- Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
- Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.
Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.